Potassium Iodide Market

The Potassium Iodide market is projected to grow at a CAGR of 5.6% between 2025 and 2035, fueled by its broad applications in medical, nutritional, and emergency preparedness contexts. It plays a critical role in protecting the thyroid gland from radioactive iodine during nuclear emergencies and is a key component in radiopharmaceuticals and thyroid disorder treatments. With increasing awareness about radiation exposure risks and rising incidences of iodine deficiency-related disorders, the demand for Potassium Iodide continues to increase. Its role in iodization of salt and use as a nutritional supplement also contributes to its widespread adoption, especially in regions where iodine deficiency is prevalent.

Geographically, North America leads the Potassium Iodide market, driven by government stockpiling programs for radiological emergencies and its established use in thyroid health management. Europe follows with high demand from both pharmaceutical and nuclear safety agencies, especially in countries with active nuclear power operations. The Asia-Pacific region is witnessing rapid growth due to ongoing salt iodization programs and increasing awareness around thyroid disorders in countries such as India and China. Latin America and the Middle East & Africa are emerging markets, where improved public health policies and greater emphasis on nutritional supplementation are driving market penetration.

Potassium Iodide continues to serve as a critical compound across public health, pharmaceutical, and industrial applications. As global focus sharpens on nuclear safety, nutritional adequacy, and thyroid disorder prevention, the market is expected to experience stable and diversified growth. Manufacturers that offer high-purity, multi-grade products and adapt to evolving public health protocols will be well-positioned to benefit in this expanding market.